Document text
Principal Investigator: William Elkins
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2021
Award: $10,368
Funding agency: National Institute of Allergy and Infectious Diseases
Since early 2020, the Infectious Disease Pathogenesis Section (IDPS) has performed pre-clinical studies and reported the resulting pre-clinical pathology safety and efficacy data to the Vaccine Research Center (VRC), Moderna, and the Food and Drug Administration (FDA). These initial studies involved pathology evaluations of multiple animal species and enabled smooth transition of the mRNA-1273 vaccine into human clinical trials. Since receiving Emergency Use Approval (EUA) from the FDA, the IDPS has continued its collaboration with the VRC in efforts to continue the advancement of the science behind this overwhelmingly safe and effective vaccine. During these studies, the IDPS participated in study design, processed over 1000 animal-sourced pathology samples, provided expertise related to sample collection and evaluation, and devised scoring algorithms to generate large datasets for multiple publications. Over the last year, the IDPS has co-authored a total of 13 COVID-19- related publications which have been accepted in a wide range of highly-respected publications including Nature, Cell, PLoS Pathogens, Immunity and The New England Journal of Medicine.
Terms: <Algorithms><Animal Model><Animal Models and Related Studies><Animal Sources><Animals><COVID><COVID-19><COVID19><CV-19><CV19><Cell Body><Cells><Clinical Pathology><Clinical Trials><CoV disease><Collaborations><Communicable Diseases><Data><Emergencies><Emergency Situation><Evaluation><Food and Drug Administration><Human><Immune response><Immunity><Immunological response><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Investigators><Journals><Magazine><Medicine><Modern Man><Moderna COVID-19 vaccine><Moderna coronavirus disease 2019 vaccine><NIAID><National Institute of Allergy and Infectious Disease><Nature><New England><Northeastern United States><Pathogenesis><Pathology><Performance><Process><Publications><Reporting><Research Design><Research Personnel><Researchers><Safety><Sampling><Science><Scientific Publication><Study Type><USFDA><United States Food and Drug Administration><Vaccine Research><Vaccines><corona virus disease><corona virus disease 2019><coronavirus disease><coronavirus disease 2019><host response><immune system response><immunoresponse><large data sets><large datasets><mRNA-1273><mRNA1273><model of animal><model organism><multiple data sets><multiple datasets><pathogen><pre-clinical><pre-clinical study><preclinical><preclinical study><sample collection><specimen collection><study design>